Yash Jay Patel

No-nonsense neuropharmacist with a plan to cure Alzheimer's.

Attributes Level
Strength 8
Dexterity 12
Intelligence 14
Health 10
Hit Points 8
Will 13
Perception 14
Fatigue Points 11
Basic Speed 4.75
Basic Move 5

Height: 5’6”
Weight: 90 lbs
Handsome, +1 on reaction rolls

Cultural Familiarity: East Asian, South Asian, Western (through parents and upbringing)

Language: English, Hindi, Korean (spoken, not written)

Wealth: Average, 60k annual salary
Independent Income, 10%, 2k monthly growth in stock value
Status 2, for founding a successful pharmaceutical company

Contact Group, effective skill 18, Polaris Venture Partners’ business skills
Common Sense
Eidetic Memory
Social Chameleon (exempt from reaction penalties due to rank or status, + 1 on those who demand respect (kings, priests))
Voice (+2 to Diplomacy, Fast-Talk, Mimicry, Performance, Politics, Public Speaking, Sex Appeal, and Singing, + 2 to reaction to anyone who can hear your voice)

Bad Temper
Professional Code of Honor (always perform ethical experiments, refuses to lie about results)
Overconfidence (make self-control roll whenever needing caution, if fail, go with it because you are totally capable of doing it, + 2 to reaction from young people, -2 to reaction for experienced)
Miserliness (make self-control roll whenever spending money, if fail, refuse to spend money, if must spend, can’t stop haggling)
Paranoia (Delusional; believes demons are trying to kill him)


Skills Level
Expert Skill (Neuropharmacology) 16
Current Affairs (Science and Tech) 14
Diplomacy 15 +2
Finance 14
Observation 14
Public Speaking 14 +2
Poetry 13
Literature 13
Cooking (Italian) 13
Fast Talk 14 +2
Detect Lies 14
Gun (Pistol) 12
Hidden Lore 12


Alcohol Tolerance
Deep Sleeper


Yash grew up the model child. He was smart, witty, obedient, and never talked back to his parents. He graduated in the top five percent of his class at West-Windsor Plainsboro HS-South. He attended the University of Pennsylvania, graduating with a B.S. in the Biological Basis of Behavior from the College of Arts and Sciences and a B.A. in Finance from the Wharton School of Business. Following that, he received an M.S. in Neuroscience from NYU, and received his Ph.D. in Pharmaceutical Sciences from Rutgers School of Pharmacy. At 28, having completed his residency at Mt. Sinai Hospital in NYC, he moved to Cambridge, Massachusetts, temporarily, to work for Biogen. After working there for two years, he moved back to New Jersey to found his own company, Operon Technologies. At 33, he is still unmarried, the head of new startup that promises to completely change the way we look at pharmaceuticals and biotechnology. The first plan of this company is to cure Alzheimer’s disease. Through a new method, known as the Patel-Zhukov Method, a combination of surgical removal of tissue, appliance of specialized neuron pathway films, injections of specific, concentrated growth and promotion factors, and a month long regimen post-op of a cocktail of drugs, the method promises a way to completely stop rapid neurodegeneration, a way to preserve neuron connections, and preserve and re-enable the process of long-term memory formation.

Yash has his fair share of problems. He is headstrong, convinced his way works; after all, that’s been life for him for years. He rarely feels like people’s business is exclusively theirs, especially when dealing with his coworkers; you shouldn’t worry if you have nothing to hide, right? His hardass behavior as a boss comes at the chagrin of his employees, but he is consistent. He never demands what he isn’t willing to do himself. For months he worked over 80 hours a week, and to this day still clocks close to 60 hours a week.

In 2015, Operon Technologies has been around for a little over three years. The company is currently worth around 100 million dollars. They currently have one drug on the market, Vitalex, a NDMA (N-methyl D-aspartate) antagonist, which helps slow the progression of symptoms of Alzheimer’s. In 2014, the company made 15 million in revenue, and spent 30 million in operating expenses, leaving the company currently with 5 million in cash and 15 million in debt.

Yash’s Published Papers

Yash Jay Patel

The Good Guys zodon1 viralmysteries